Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
PharmaTher Holdings Ltd (QB) (PHRRF)
PharmaTher Holdings Ltd (QB) (PHRRF) Actualités

PHRRF

PharmaTher (QB) (PHRRF)

PharmaTher Holdings Ltd (QB)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:PHRRF

1

Date	Heure	Source	Titre	Symbole	Société
19/09/2022	12h31	TipRanks	Analysts Offer Insights on Healthcare Companies: PharmaTher Holdings Ltd (OtherPHRRF), Rezolute (RZLT) and ADC Therapeutics (ADCT)	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
15/06/2022	11h03	TipRanks	H.C. Wainwright Keeps a Buy Rating on PharmaTher Holdings Ltd (PHRRF)	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
22/11/2021	12h16	TipRanks	H.C. Wainwright Thinks NPharmaTher’s Stock is Going to Recover	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
11/11/2021	16h00	InvestorsHub NewsWire	PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
03/11/2021	13h03	InvestorsHub NewsWire	PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
19/10/2021	13h07	InvestorsHub NewsWire	PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
13/10/2021	15h20	InvestorsHub NewsWire	PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
21/09/2021	16h19	InvestorsHub NewsWire	PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
13/09/2021	15h03	InvestorsHub NewsWire	PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
04/08/2021	14h15	InvestorsHub NewsWire	PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
21/07/2021	14h19	InvestorsHub NewsWire	PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
16/06/2021	17h14	InvestorsHub NewsWire	PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
25/05/2021	14h45	InvestorsHub NewsWire	PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
17/05/2021	14h02	InvestorsHub NewsWire	PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson's Disease	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
27/04/2021	13h47	InvestorsHub NewsWire	PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics..Cont	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
20/04/2021	14h00	InvestorsHub NewsWire	PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
15/04/2021	17h32	InvestorsHub NewsWire	PharmaTher Provides Update on Psychedelic Product Programs	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
02/03/2021	13h34	InvestorsHub NewsWire	PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou....Cont	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
17/02/2021	16h11	InvestorsHub NewsWire	PharmaTher Announces Sale of Psilocybin Program	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
04/02/2021	14h21	InvestorsHub NewsWire	PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
01/02/2021	14h19	InvestorsHub NewsWire	PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
19/01/2021	14h07	InvestorsHub NewsWire	PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)

Showing the most relevant articles for your search:USOTC:PHRRF

1

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales